TNF and rheumatoid arthritis: However, in non-melanoma skin cancer, a meta-analysis including 10 prospective observational studies demonstrated that TNF inhibitor use in patients with RA increased the risk of non-melanoma skin cancer (pooled relative risk = 1.28, 95% CI 1.19–1.38) [110].